Agnieszka Baranowska-Bik

9PUBLICATIONS
5CO-AUTHORS
Medical biochemistry - amino acids and metabolitesPredictive and prognostic markersPacific Peoples medicine and treatmentsNeurology and neuromuscular diseasesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
Potential Neuroprotective Role of GLP-2 in Alzheimer's Disease: Clinical Observations, Mechanistic Insights, and Comparison with GLP-1.

Maciej Czarnecki, Agnieszka Baranowska-Bik, Anna Litwiniuk

|Jun 28, 2023
In the Pursuit of Metabolic Markers of Systemic Sclerosis-Plasma Adiponectin and Omentin-1 in Monitoring the Course of the Disease.

Klaudia Dopytalska, Małgorzata Kalisz, Anna Litwiniuk

|Sep 05, 2022
Therapy of obesity in women with PCOS using GLP-1 analogues - benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 - korzyści i ograniczenia].

Agnieszka Baranowska-Bik

|Dec 28, 2021
Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases.

Anna Litwiniuk, Agnieszka Baranowska-Bik, Anita Domańska

|Sep 16, 2021
The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease.

Anita Domańska, Arkadiusz Orzechowski, Anna Litwiniuk

|Jun 02, 2021
Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.

Anna Litwiniuk, Wojciech Bik, Małgorzata Kalisz

Pageof 2

Frequent Collaborators

4 joint publications

Anna Litwiniuk

3 joint publications

Wojciech Bik

1 joint publications

Anita Domańska

1 joint publications

Arkadiusz Orzechowski